Outlook Therapeutics, Inc.
OTLK
Revenue
5.85M
▲5.27M▲902.58%
3 Months ChangeAssets
47.09M
▼-11.94M▼-20.22%
3 Months ChangeLiabilities
130.77M
▼-62.50M▼-32.34%
3 Months ChangeFree Cash Flow
-10.02M
▼-271.59k▼-2.79%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001558370-24-012234
2024-08-14
Form 8-K
ID: 0001104659-24-089325
2024-07-08
Form 8-K
ID: 0001104659-24-078207
2024-05-28
Form 8-K
ID: 0001104659-24-065609
2024-05-15
Form 8-K
ID: 0001104659-24-062054
2024-05-15
Form 10-Q
ID: 0001558370-24-008318
2024-05-13
Form 8-K
ID: 0001104659-24-060517
2024-05-01
Form 8-K
ID: 0001104659-24-055141
2024-04-15
Form 8-K
ID: 0001104659-24-047322
2024-04-12
Form 8-K
ID: 0001104659-24-046752